Pfizer considers purchase of India's Agila Specialties

Pfizer Inc is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd , for a possible price of USD 2 billion, Bloomberg reported on Monday.

Pfizer is doing due diligence and a deal could be reached this quarter, Bloomberg reported, citing unnamed sources.

Pfizer's shares volumes increase after 2 big block deals

A Pfizer spokeswoman said the company does not comment on market rumours or speculation.

Agila makes cancer treatments and antibiotics, Bloomberg said.

Pfizer shares were up 23 cents at USD 26.75 on the New York Stock Exchange.

Anda sedang membaca artikel tentang

Pfizer considers purchase of India's Agila Specialties

Dengan url

http://sehatkafein.blogspot.com/2013/01/pfizer-considers-purchase-of-indias.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Pfizer considers purchase of India's Agila Specialties

namun jangan lupa untuk meletakkan link

Pfizer considers purchase of India's Agila Specialties

sebagai sumbernya